{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:52:57Z","timestamp":1791067977339,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier","isbn-type":[{"value":"9780443472169","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100024586","name":"Human Resource Development Centre, Council of Scientific And Industrial Research","doi-asserted-by":"publisher","award":["09\/0475(23353)\/2025-EMR-I"],"award-info":[{"award-number":["09\/0475(23353)\/2025-EMR-I"]}],"id":[{"id":"10.13039\/501100024586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Anusandhan National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.irn.2026.06.003","type":"book-chapter","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:25:59Z","timestamp":1782386759000},"page":"487-507","source":"Crossref","is-referenced-by-count":0,"title":["Peripheral manifestations of nigrostriatal neurodegeneration in Parkinson\u2019s disease"],"prefix":"10.1016","author":[{"given":"Jerly Helan Mary","family":"Joseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Kandasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/bs.irn.2026.06.003_bib1","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/acn3.50944","article-title":"\u03b1\u2010Synuclein in blood cells differentiates Parkinson\u2019s disease from healthy controls","volume":"6","author":"Abd Elhadi","year":"2019","journal-title":"Annals of Clinical and Translational Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2026.06.003_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ana.10675","article-title":"The role of pathogenic DJ-1 mutations in Parkinson\u2019s disease","volume":"54","author":"Abou-Sleiman","year":"2003","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.irn.2026.06.003_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2026.108332","article-title":"The influence of beta-amyloid and tau proteins on cognitive changes in Parkinson\u2019s disease","author":"Abraham","year":"2026","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2026.06.003_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neulet.2010.08.007","article-title":"Elevation of oxidized DJ-1 in the brain and erythrocytes of Parkinson disease model animals","volume":"483","author":"Akazawa","year":"2010","journal-title":"Neuroscience Letters"},{"issue":"20","key":"10.1016\/bs.irn.2026.06.003_bib5","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1212\/WNL.0000000000000425","article-title":"CSF A\u03b242 predicts early-onset dementia in Parkinson disease","volume":"82","author":"Alves","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2026.06.003_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neulet.2017.12.023","article-title":"Expression of the DJ-1 protein in the serum of Chinese patients with Parkinson\u2019s disease","volume":"665","author":"An","year":"2018","journal-title":"Neuroscience Letters"},{"issue":"5","key":"10.1016\/bs.irn.2026.06.003_bib7","first-page":"456","article-title":"[Function of DJ]-1, a causative gene for familial Parkinson\u2019s disease]","volume":"76","author":"Ariga","year":"2004","journal-title":"Seikagaku. the Journal of Japanese Biochemical Society"},{"key":"10.1016\/bs.irn.2026.06.003_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.dscb.2024.100163","article-title":"Novel approaches targeting \u03b1-Synuclein for Parkinson\u2019s disease: Current progress and future directions for the disease-modifying therapies","volume":"16","author":"Baggett","year":"2024","journal-title":"Brain Disorders"},{"key":"10.1016\/bs.irn.2026.06.003_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2025.09.025","article-title":"DJ-1\/PARK7 in Parkinson\u2019s disease: Mechanisms of pathogenesis and therapeutic potential","volume":"587","author":"Bao","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/bs.irn.2026.06.003_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/bs.irn.2023.11.001","article-title":"A general clinical overview of the non-motor symptoms in Parkinson\u2019s disease: Neuropsychiatric symptoms","volume":"174","author":"Batzu","year":"2024","journal-title":"International Review of Neurobiology"},{"issue":"1","key":"10.1016\/bs.irn.2026.06.003_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41531-022-00384-x","article-title":"Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson\u2019s disease","volume":"8","author":"Batzu","year":"2022","journal-title":"Npj Parkinson\u2019s Disease"},{"key":"10.1016\/bs.irn.2026.06.003_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.01399","article-title":"Alpha-synuclein physiology and pathology: A perspective on cellular structures and organelles","volume":"13","author":"Bernal-Conde","year":"2020","journal-title":"Frontiers in Neuroscience"},{"issue":"9","key":"10.1016\/bs.irn.2026.06.003_bib13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00415-025-13325-4","article-title":"CSF phospho-tau levels at Parkinson\u2019s disease onset predict the risk for development of motor complications","volume":"272","author":"Bissacco","year":"2025","journal-title":"Journal of Neurology"},{"issue":"5604","key":"10.1016\/bs.irn.2026.06.003_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science (New York, N. Y.)"},{"issue":"2","key":"10.1016\/bs.irn.2026.06.003_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiology of Aging"},{"issue":"6","key":"10.1016\/bs.irn.2026.06.003_bib16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00702-023-02632-7","article-title":"Blood neurofilament light chain in Parkinson\u2019s disease","volume":"130","author":"Buhmann","year":"2023","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/bs.irn.2026.06.003_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2017.02.045","article-title":"MicroRNA biomarkers of Parkinson\u2019s disease in serum exosome-like microvesicles","volume":"644","author":"Cao","year":"2017","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2026.06.003_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.00112","article-title":"Plasma levels of \u03b1-synuclein, A\u03b2-40 and T-tau as biomarkers to predict cognitive impairment in Parkinson\u2019s disease","volume":"12","author":"Chen","year":"2020","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"6","key":"10.1016\/bs.irn.2026.06.003_bib19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson\u2019s disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Annals of Neurology"},{"issue":"16","key":"10.1016\/bs.irn.2026.06.003_bib20","doi-asserted-by":"crossref","first-page":"10816","DOI":"10.1074\/jbc.M509079200","article-title":"Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases","volume":"281","author":"Choi","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/bs.irn.2026.06.003_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.17219\/acem\/112058","article-title":"Plasma tau protein and A\u03b242 level as markers of cognitive impairment in patients with Parkinson\u2019s disease","volume":"29","author":"Chojdak-\u0141ukasiewicz","year":"2020","journal-title":"Advances in Clinical and Experimental Medicine"},{"issue":"10","key":"10.1016\/bs.irn.2026.06.003_bib22","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100787R","article-title":"Plasma extracellular vesicles tau and \u03b2-amyloid as biomarkers of cognitive dysfunction of Parkinson\u2019s disease","volume":"35","author":"Chung","year":"2021","journal-title":"FASEB Journal"},{"issue":"5","key":"10.1016\/bs.irn.2026.06.003_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/biom13050865","article-title":"Serum and exosomal miR-7-1-5p and miR-223-3p as possible biomarkers for Parkinson\u2019s disease","volume":"13","author":"Citterio","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/bs.irn.2026.06.003_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.690013","article-title":"Neurofilament levels are reflecting the loss of presynaptic dopamine receptors in movement disorders","volume":"15","author":"Diek\u00e4mper","year":"2021","journal-title":"Frontiers in Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2026.06.003_bib25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00702-016-1650-2","article-title":"Relationship between the plasma levels of neurodegenerative proteins and motor subtypes of Parkinson\u2019s disease","volume":"124","author":"Ding","year":"2017","journal-title":"Journal of Neural Transmission"},{"issue":"11","key":"10.1016\/bs.irn.2026.06.003_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206536","article-title":"Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson\u2019s disease diagnosis","volume":"13","author":"Dos Santos","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.irn.2026.06.003_bib27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/mds.22928","article-title":"Plasma \u03b1-synuclein in patients with Parkinson\u2019s disease with and without treatment","volume":"25","author":"Duran","year":"2010","journal-title":"Movement Disorders"},{"issue":"8","key":"10.1016\/bs.irn.2026.06.003_bib28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/14737159.2017.1341312","article-title":"Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson\u2019s disease","volume":"17","author":"Farotti","year":"2017","journal-title":"Expert Review of Molecular Diagnostics"},{"issue":"10","key":"10.1016\/bs.irn.2026.06.003_bib29","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1007\/s10072-024-07599-1","article-title":"From lab bench to hope: A review of gene therapies in clinical trials for Parkinson\u2019s disease and challenges","volume":"45","author":"Grote","year":"2024","journal-title":"Neurological Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2026.06.003_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1523\/JNEUROSCI.2507-13.2014","article-title":"\u03b1-Synuclein is localized to mitochondria-associated ER membranes","volume":"34","author":"Guardia-Laguarta","year":"2014","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2026.06.003_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.648151","article-title":"Genetic analysis and literature review of SNCA variants in Parkinson\u2019s disease","volume":"13","author":"Guo","year":"2021","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"6","key":"10.1016\/bs.irn.2026.06.003_bib32","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nature Medicine"},{"issue":"10","key":"10.1016\/bs.irn.2026.06.003_bib33","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based NfL","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2026.06.003_bib34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: A case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"The Lancet Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2026.06.003_bib35","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s12035-018-1151-4","article-title":"Peripheral biomarkers for early detection of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"56","author":"Htike","year":"2019","journal-title":"Molecular Neurobiology"},{"issue":"1","key":"10.1016\/bs.irn.2026.06.003_bib36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41531-025-01091-z","article-title":"Elevated plasma levels of alpha-synuclein are dispensable for Parkinson\u2019s disease pathology","volume":"11","author":"Jeong","year":"2025","journal-title":"Npj Parkinson\u2019s Disease"},{"key":"10.1016\/bs.irn.2026.06.003_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuroscience.2014.04.039","article-title":"Downregulation of miR-124 in MPTP-treated mouse model of Parkinson\u2019s disease and MPP iodide-treated MN9D cells modulates the expression of the calpain\/cdk5 pathway proteins","volume":"272","author":"Kanagaraj","year":"2014","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2026.06.003_bib38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/prca.201200087","article-title":"Apolipoprotein A-I: Insights from redox proteomics for its role in neurodegeneration","volume":"7","author":"Keeney","year":"2013","journal-title":"Proteomics \u2013 Clinical Applications"},{"issue":"9","key":"10.1016\/bs.irn.2026.06.003_bib39","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1093\/brain\/awac115","article-title":"Detection of neuron-derived pathological \u03b1-synuclein in blood","volume":"145","author":"Kluge","year":"2022","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.irn.2026.06.003_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41531-018-0049-1","article-title":"Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity","volume":"4","author":"Kluss","year":"2018","journal-title":"NPJ Parkinson\u2019s disease"},{"key":"10.1016\/bs.irn.2026.06.003_bib41","first-page":"3","article-title":"Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis","author":"Kouli","year":"2018","journal-title":"Exon Publications"},{"key":"10.1016\/bs.irn.2026.06.003_bib42","series-title":"Multiple sclerosis: Methods and protocols","first-page":"93","article-title":"Neurofilament light chain determination from peripheral blood samples","author":"Limberg","year":"2016"},{"issue":"11","key":"10.1016\/bs.irn.2026.06.003_bib43","doi-asserted-by":"crossref","first-page":"e1104","DOI":"10.1212\/WNL.0000000000008088","article-title":"Blood NfL","volume":"93","author":"Lin","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2026.06.003_bib44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/ane.13517","article-title":"Plasma total tau predicts executive dysfunction in Parkinson\u2019s disease","volume":"145","author":"Lin","year":"2022","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/bs.irn.2026.06.003_bib45","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/srep00954","article-title":"DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease","volume":"2","author":"Lin","year":"2012","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.irn.2026.06.003_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35766-w","article-title":"Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease","volume":"8","author":"Lin","year":"2018","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.irn.2026.06.003_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12964-025-02136-9","article-title":"Neuroprotective role and mechanistic insights of DJ-1 dimerization in Parkinson\u2019s disease","volume":"23","author":"Lv","year":"2025","journal-title":"Cell Communication and Signaling"},{"issue":"7","key":"10.1016\/bs.irn.2026.06.003_bib48","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/cbf.3224","article-title":"Serum miR-221 serves as a biomarker for Parkinson\u2019s disease","volume":"34","author":"Ma","year":"2016","journal-title":"Cell Biochemistry and Function"},{"key":"10.1016\/bs.irn.2026.06.003_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4137\/BMI.S11422","article-title":"Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson\u2019s disease cases lacking Alzheimer\u2019s disease pathology","volume":"8","author":"Maarouf","year":"2013","journal-title":"Biomarker Insights"},{"key":"10.1016\/bs.irn.2026.06.003_bib50","article-title":"Pathophysiology of motor dysfunction in Parkinson\u2019s disease as the rationale for drug treatment and rehabilitation","volume":"2016","author":"Magrinelli","year":"2016","journal-title":"Parkinson\u2019s Disease"},{"key":"10.1016\/bs.irn.2026.06.003_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148271","article-title":"Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson\u2019s disease","volume":"1805","author":"Mao","year":"2023","journal-title":"Brain Research"},{"issue":"12","key":"10.1016\/bs.irn.2026.06.003_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122623","article-title":"Neuron-astrocyte interactions in Parkinson\u2019s disease","volume":"9","author":"Miyazaki","year":"2020","journal-title":"Cells"},{"key":"10.1016\/bs.irn.2026.06.003_bib53","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2012.11.004","article-title":"Total CSF \u03b1-synuclein is lower in de novo Parkinson patients than in healthy subjects","volume":"532","author":"Mollenhauer","year":"2013","journal-title":"Neuroscience Letters"},{"issue":"2","key":"10.1016\/bs.irn.2026.06.003_bib54","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/bbrc.1997.6132","article-title":"DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation withras","volume":"231","author":"Nagakubo","year":"1997","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"9","key":"10.1016\/bs.irn.2026.06.003_bib55","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease","volume":"46","author":"Nalls","year":"2014","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.irn.2026.06.003_bib56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.12703\/r\/10-46","article-title":"Neurofilament light: A narrative review on biomarker utility","volume":"10","author":"Narayanan","year":"2021","journal-title":"Faculty Reviews"},{"key":"10.1016\/bs.irn.2026.06.003_bib57","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.parkreldis.2021.07.028","article-title":"Serum neurofilament is associated with motor function, cognitive decline and subclinical cardiac damage in advanced Parkinson\u2019s disease (MARK-PD)","volume":"90","author":"Niemann","year":"2021","journal-title":"Parkinsonism & Related Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2026.06.003_bib58","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3233\/JAD-180325","article-title":"Glial fibrillary acidic protein in serum is increased in Alzheimer\u2019s disease and correlates with cognitive impairment","volume":"67","author":"Oeckl","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"1","key":"10.1016\/bs.irn.2026.06.003_bib59","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neulet.2006.05.031","article-title":"Establishment of specific antibodies that recognize C106-oxidized DJ-1","volume":"404","author":"Ooe","year":"2006","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2026.06.003_bib60","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.parkreldis.2022.05.020","article-title":"Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson\u2019s disease","volume":"105","author":"Pagonabarraga","year":"2022","journal-title":"Parkinsonism & Related Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2026.06.003_bib61","article-title":"The challenge of disease-modifying therapies in Parkinson\u2019s disease: Role of CSF biomarkers","volume":"10","author":"Paoletti","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/bs.irn.2026.06.003_bib62","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41582-024-01043-w","article-title":"\u03b1-Synuclein pathology as a target in neurodegenerative diseases","volume":"21","author":"Park","year":"2025","journal-title":"Nature Reviews Neurology"},{"key":"10.1016\/bs.irn.2026.06.003_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2014.00053","article-title":"Differential role of CSF alpha-synuclein species, tau, and A\u03b242 in Parkinson\u2019s disease","volume":"6","author":"Parnetti","year":"2014","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2026.06.003_bib64","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.parkreldis.2008.05.004","article-title":"LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson\u2019s disease","volume":"15","author":"Patra","year":"2009","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2026.06.003_bib65","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.23872","article-title":"Plasma apolipoprotein A1 as a biomarker for Parkinson disease","volume":"74","author":"Qiang","year":"2013","journal-title":"Annals of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2026.06.003_bib66","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s00415-017-8403-5","article-title":"Does apolipoprotein A1 predict microstructural changes in subgenual cingulum in early Parkinson?","volume":"264","author":"Rahmani","year":"2017","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2026.06.003_bib67","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.resuscitation.2012.07.027","article-title":"Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: Results of a pilot study","volume":"84","author":"Randall","year":"2013","journal-title":"Resuscitation"},{"issue":"9","key":"10.1016\/bs.irn.2026.06.003_bib68","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/jcm8091377","article-title":"DJ-1 in Parkinson\u2019s disease: Clinical insights and therapeutic perspectives","volume":"8","author":"Repici","year":"2019","journal-title":"Journal of Clinical Medicine"},{"issue":"5","key":"10.1016\/bs.irn.2026.06.003_bib69","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00109-012-0976-y","article-title":"Parkinson\u2019s disease-associated mutations in DJ-1 modulate its dimerization in living cells","volume":"91","author":"Repici","year":"2013","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"key":"10.1016\/bs.irn.2026.06.003_bib70","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jns.2017.08.2187","article-title":"Abnormally high levels of oxidized DJ-1 in cases of Parkinson\u2019s disease (PD) and dementia with lewy bodies (DLB)","volume":"381","author":"Saigoh","year":"2017","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1016\/bs.irn.2026.06.003_bib71","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3164\/jcbn.13-108","article-title":"Oxidized DJ-1 as a possible biomarker of Parkinson\u2019s disease","volume":"54","author":"Saito","year":"2014","journal-title":"Journal of Clinical Biochemistry and Nutrition"},{"issue":"25","key":"10.1016\/bs.irn.2026.06.003_bib72","doi-asserted-by":"crossref","first-page":"17455","DOI":"10.18632\/oncotarget.24736","article-title":"miRNAbased signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson\u2019s disease","volume":"9","author":"Santos","year":"2018","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/bs.irn.2026.06.003_bib73","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nature Reviews. Neuroscience"},{"issue":"7","key":"10.1016\/bs.irn.2026.06.003_bib74","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1212\/WNL.0b013e318264e353","article-title":"Large-scale replication and heterogeneity in Parkinson disease genetic loci","volume":"79","author":"Sharma","year":"2012","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2026.06.003_bib75","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jalz.2016.04.003","article-title":"CNS tau efflux via exosomes is likely increased in Parkinson\u2019s disease but not in Alzheimer\u2019s disease","volume":"12","author":"Shi","year":"2016","journal-title":"Alzheimer\u2019s & Dementia: The Journal of the Alzheimer\u2019s Association"},{"issue":"1","key":"10.1016\/bs.irn.2026.06.003_bib76","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2010.06.009","article-title":"Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson\u2019s disease","volume":"480","author":"Shi","year":"2010","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2026.06.003_bib77","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12813","article-title":"Phosphoproteomics reveals that Parkinson\u2019s disease kinase LRRK2 regulates a subset of Rab GTPases","volume":"5","author":"Steger","year":"2016","journal-title":"Elife"},{"issue":"12","key":"10.1016\/bs.irn.2026.06.003_bib78","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/mds.26290","article-title":"Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson\u2019s disease patients","volume":"30","author":"Swanson","year":"2015","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2026.06.003_bib79","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41531-023-00447-7","article-title":"Plasma GFAP in Parkinson\u2019s disease with cognitive impairment and its potential to predict conversion to dementia","volume":"9","author":"Tang","year":"2023","journal-title":"Npj Parkinson\u2019s Disease"},{"key":"10.1016\/bs.irn.2026.06.003_bib80","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40035-019-0155-y","article-title":"Erythrocytic \u03b1-Synuclein as a potential biomarker for Parkinson\u2019s disease","volume":"8","author":"Tian","year":"2019","journal-title":"Translational Neurodegeneration"},{"issue":"9","key":"10.1016\/bs.irn.2026.06.003_bib81","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00702-022-02498-1","article-title":"Blood-based biomarker in Parkinson\u2019s disease: Potential for future applications in clinical research and practice","volume":"129","author":"T\u00f6nges","year":"2022","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/bs.irn.2026.06.003_bib82","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3389\/fnins.2020.00443","article-title":"LRRK2 at the interface between peripheral and central immune function in Parkinson\u2019s","volume":"14","author":"Wallings","year":"2020","journal-title":"Frontiers in Neuroscience"},{"issue":"5","key":"10.1016\/bs.irn.2026.06.003_bib83","first-page":"350","article-title":"Tetranectin and apolipoprotein A-I in cerebrospinal fluid as potential biomarkers for Parkinson\u2019s disease","volume":"122","author":"Wang","year":"2010","journal-title":"Acta Neurologica Scandinavica"},{"issue":"3","key":"10.1016\/bs.irn.2026.06.003_bib84","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bbrc.2006.05.011","article-title":"Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson\u2019s disease","volume":"345","author":"Waragai","year":"2006","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"9","key":"10.1016\/bs.irn.2026.06.003_bib85","first-page":"542","article-title":"Parkinson\u2019s disease","volume":"44","author":"Williams-Gray","year":"2016","journal-title":"Medicine, Neurology (Part 2 of 2)"},{"key":"10.1016\/bs.irn.2026.06.003_bib86","article-title":"Plasma miR-153 and miR-223 levels as potential biomarkers in Parkinson\u2019s disease","volume":"16","author":"Wu","year":"2022","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.irn.2026.06.003_bib87","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neures.2017.06.008","article-title":"Diagnosis of Parkinson\u2019s disease and the level of oxidized DJ-1 protein","volume":"128","author":"Yamagishi","year":"2018","journal-title":"Neuroscience Research"},{"issue":"5","key":"10.1016\/bs.irn.2026.06.003_bib88","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1021\/acschemneuro.8b00460","article-title":"Altered expression levels of MicroRNA-132 and Nurr1 in peripheral blood of Parkinson\u2019s Disease: Potential disease biomarkers","volume":"10","author":"Yang","year":"2019","journal-title":"ACS Chemical Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2026.06.003_bib89","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s41598-022-05227-6","article-title":"Early downregulation of hsa-miR-144-3p in serum from drug-na\u00efve Parkinson\u2019s disease patients","volume":"12","author":"Zago","year":"2022","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.irn.2026.06.003_bib90","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1038\/s41467-024-49949-9","article-title":"Neuroimaging and fluid biomarkers in Parkinson\u2019s disease in an era of targeted interventions","volume":"15","author":"Zarkali","year":"2024","journal-title":"Nature Communications"},{"issue":"4","key":"10.1016\/bs.irn.2026.06.003_bib91","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1309\/W01Y0B808EMEH12L","article-title":"CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases","volume":"129","author":"Zhang","year":"2008","journal-title":"American Journal of Clinical Pathology"},{"issue":"2","key":"10.1016\/bs.irn.2026.06.003_bib92","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1039\/C1AN15551B","article-title":"Quantitative proteomic analysis of serum proteins in patients with Parkinson\u2019s disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry","volume":"137","author":"Zhang","year":"2011","journal-title":"Analyst"},{"key":"10.1016\/bs.irn.2026.06.003_bib93","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fnagi.2018.00438","article-title":"Increased DJ-1 and \u03b1-synuclein in plasma neural-derived exosomes as potential markers for Parkinson\u2019s disease","volume":"10","author":"Zhao","year":"2018","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/bs.irn.2026.06.003_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00438","article-title":"Increased DJ-1 and \u03b1-synuclein in plasma neural-derived exosomes as potential markers for Parkinson\u2019s disease","volume":"10","author":"Zhao","year":"2019","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/bs.irn.2026.06.003_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/srep44872","article-title":"Phenotype of postural instability\/gait difficulty in Parkinson disease: Relevance to cognitive impairment and mechanism relating pathological proteins and neurotransmitters","volume":"7","author":"Zuo","year":"2017","journal-title":"Scientific Reports"}],"container-title":["International Review of Neurobiology","Blood-Based Biomarkers for Alzheimers and Parkinsons Disease - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:56:59Z","timestamp":1791064619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774226000656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443472169"],"references-count":95,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2026.06.003","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}